Borderline leprosy and Type 2 lepra reaction

Summary:

Type 2 lepra reaction is found among people with Borderline leprosy, especially for people who are male, 20-29 old.

The study analyzes which people have Type 2 lepra reaction with Borderline leprosy. It is created by eHealthMe based on reports of 12 people who have Borderline leprosy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Borderline leprosy?

Borderline leprosy is found to be associated with 4 drugs and 12 conditions by eHealthMe. Check the latest studies of Borderline leprosy.

What is Type 2 lepra reaction?

Type 2 lepra reaction is found to be associated with 15 drugs and 18 conditions by eHealthMe. Check the latest studies of Type 2 lepra reaction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

12 people who have Borderline Leprosy and Type 2 Lepra Reaction are studied.

Would you have Type 2 lepra reaction when you have Borderline leprosy?

Gender of people who have Borderline Leprosy and experienced Type 2 Lepra Reaction *:

female: 0.0 %
male: 100 %

Age of people who have Borderline Leprosy and experienced Type 2 Lepra Reaction *:

Common co-existing conditions for these people *:

Leprosy (a disfiguring disease caused by the mycobacterium leprae bacteria): 1 person, 8.33%

Common drugs taken by these people *:

Minocycline: 6 people, 50.00%
Pyridoxine Hcl: 1 person, 8.33%
Pyridoxine: 1 person, 8.33%
Pyrazinamide: 1 person, 8.33%
Penicillin: 1 person, 8.33%
Moxifloxacin: 1 person, 8.33%
Isoniazid: 1 person, 8.33%
Ethambutol Hydrochloride: 1 person, 8.33%
Dapsone: 1 person, 8.33%

Common symptoms for these people *:

Therapeutic Response Decreased (less preventive response): 6 people, 50.00%
Skin Hyperpigmentation (disorders affect the colour of your skin): 6 people, 50.00%
Drug Dependence: 6 people, 50.00%
Drug Ineffective: 4 people, 33.33%
Infection: 3 people, 25.00%
Renal Impairment (severely reduced kidney function): 2 people, 16.67%
Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 16.67%
Oedema Peripheral (superficial swelling): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Haematuria (presence of blood in urine): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Type 2 lepra reaction?

- Check whether Type 2 lepra reaction is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Type 2 lepra reaction and Borderline leprosy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.